Synopsis
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - GEL;TOPICAL - 5%;3%
USFDA APPLICATION NUMBER - 50557
DOSAGE - TABLET, COATED PARTICLES;ORAL - 333M...DOSAGE - TABLET, COATED PARTICLES;ORAL - 333MG
USFDA APPLICATION NUMBER - 50611
DOSAGE - TABLET, COATED PARTICLES;ORAL - 500M...DOSAGE - TABLET, COATED PARTICLES;ORAL - 500MG
USFDA APPLICATION NUMBER - 50611
DOSAGE - GEL;TOPICAL - 2%
USFDA APPLICATION NUMBER - 50617
DOSAGE - GEL;TOPICAL - 5%;3%
USFDA APPLICATION NUMBER - 50769
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Cerata Pharmaceuticals LLP
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Controlled & Modified Release
Topical
Granulation
Direct Compression
Solubilizers
Lubricants & Glidants
Emulsifying Agents
Film Formers & Plasticizers
Co-Processed Excipients
Empty Capsules
Chewable & Orodispersible Aids
API Stability Enhancers
Parenteral
Taste Masking
Vegetarian Capsules
Rheology Modifiers
Surfactant & Foaming Agents
Coloring Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
64
PharmaCompass offers a list of Erythromycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Erythromycin manufacturer or Erythromycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Erythromycin manufacturer or Erythromycin supplier.
PharmaCompass also assists you with knowing the Erythromycin API Price utilized in the formulation of products. Erythromycin API Price is not always fixed or binding as the Erythromycin Price is obtained through a variety of data sources. The Erythromycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Akne-Mycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Akne-Mycin, including repackagers and relabelers. The FDA regulates Akne-Mycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Akne-Mycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Akne-Mycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Akne-Mycin supplier is an individual or a company that provides Akne-Mycin active pharmaceutical ingredient (API) or Akne-Mycin finished formulations upon request. The Akne-Mycin suppliers may include Akne-Mycin API manufacturers, exporters, distributors and traders.
click here to find a list of Akne-Mycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Akne-Mycin DMF (Drug Master File) is a document detailing the whole manufacturing process of Akne-Mycin active pharmaceutical ingredient (API) in detail. Different forms of Akne-Mycin DMFs exist exist since differing nations have different regulations, such as Akne-Mycin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Akne-Mycin DMF submitted to regulatory agencies in the US is known as a USDMF. Akne-Mycin USDMF includes data on Akne-Mycin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Akne-Mycin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Akne-Mycin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Akne-Mycin Drug Master File in Japan (Akne-Mycin JDMF) empowers Akne-Mycin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Akne-Mycin JDMF during the approval evaluation for pharmaceutical products. At the time of Akne-Mycin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Akne-Mycin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Akne-Mycin Drug Master File in Korea (Akne-Mycin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Akne-Mycin. The MFDS reviews the Akne-Mycin KDMF as part of the drug registration process and uses the information provided in the Akne-Mycin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Akne-Mycin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Akne-Mycin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Akne-Mycin suppliers with KDMF on PharmaCompass.
A Akne-Mycin CEP of the European Pharmacopoeia monograph is often referred to as a Akne-Mycin Certificate of Suitability (COS). The purpose of a Akne-Mycin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Akne-Mycin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Akne-Mycin to their clients by showing that a Akne-Mycin CEP has been issued for it. The manufacturer submits a Akne-Mycin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Akne-Mycin CEP holder for the record. Additionally, the data presented in the Akne-Mycin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Akne-Mycin DMF.
A Akne-Mycin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Akne-Mycin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Akne-Mycin suppliers with CEP (COS) on PharmaCompass.
A Akne-Mycin written confirmation (Akne-Mycin WC) is an official document issued by a regulatory agency to a Akne-Mycin manufacturer, verifying that the manufacturing facility of a Akne-Mycin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Akne-Mycin APIs or Akne-Mycin finished pharmaceutical products to another nation, regulatory agencies frequently require a Akne-Mycin WC (written confirmation) as part of the regulatory process.
click here to find a list of Akne-Mycin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Akne-Mycin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Akne-Mycin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Akne-Mycin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Akne-Mycin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Akne-Mycin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Akne-Mycin suppliers with NDC on PharmaCompass.
Akne-Mycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Akne-Mycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Akne-Mycin GMP manufacturer or Akne-Mycin GMP API supplier for your needs.
A Akne-Mycin CoA (Certificate of Analysis) is a formal document that attests to Akne-Mycin's compliance with Akne-Mycin specifications and serves as a tool for batch-level quality control.
Akne-Mycin CoA mostly includes findings from lab analyses of a specific batch. For each Akne-Mycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Akne-Mycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Akne-Mycin EP), Akne-Mycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Akne-Mycin USP).
